They will insist immunizations have a long safety profile. 

They will claim that the chance of harm from any of Big Pharma's injectable product lines is one-in-a-million. 

But are they correct? 

Almost surely not. But don't take our word for it. 

The BMJ medical journal has never been one to shy away from delivering medical findings, nor to demand transparency while other journals play it safe. The BMJ's recent analysis looks at the World Health Organization's (WHO) rollout of the malaria vaccine in Africa. 

Professors Peter Aaby and Christine Stabell Benn, two authors of the recent BMJ analysis, are asking seemingly obvious questions about vaccine safety that much of the medical community works hard to ignore.